SPLPETRO2023-10-012023-12-31 SPLPETRO2023-10-012023-12-31 SPLPETRO2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member SPLPETRO2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member SPLPETRO2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500405 SPLPETRO NOTLISTED Supreme Petrochem Limited Equity 2023-04-01 2024-03-31 2024-01-18 2024-01-08 INR Lakhs Third quarter 16:00:00 18:30:00 2024-01-18 2024-01-18 Not applicable Single segment The Company operates in Styrenics and Allied Products which in the context of Ind AS - 108 Operating Segments consitutes a single reportable business segment. 2023-10-01 2023-12-31 Unaudited Standalone 11876806000.00 156370000.00 12033176000.00 7001239000.00 2977063000.00 132480000.00 173689000.00 29862000.00 150803000.00 643968000.00 11109104000.00 924072000.00 0.00 924072000.00 258800000.00 -11403000.00 247397000.00 0.00 676675000.00 0.00 0.00 0.00 0.00 676675000.00 -2093000.00 674582000.00 0.00 0.00 376083000.00 2 3.60 3.60 0.00 0.00 3.60 3.60 1. Phase 1 of Mass ABS project with 70,000 TPA capacity under license from M/s. Versalis SPA, Italy is progressing as per schedule. 2. The Company has entered into a Power Delivery Agreement with TP Saturn Limited on October 10, 2023 and has since entered into Shareholder Agreement and Share Purchase Agreement on December 14, 2023, to acquire 26% equity shares in TP Saturn Limited, a Special Purpose Vehicle (SPV) formed by Tata Power Renewable Energy Ltd., for supplying solar power energy of 12.5 MW (i.e. 17.95 MWp) to the Company's plant at Amdoshi, Dist. Raigad, Maharashtra. 3. Pursuant to the sub-division of the equity shares of the Company, equity share having a face value of Rs. 4/- per share (fully paid-up) was sub-divided into 2 equity shares having a face value of Rs.2/- per share (fully paid-up) with effect from December 22, 2022. 4. Figures for the quarter and nine months ended December 31, 2022, have been re-grouped/reclassified, to conform to current period's classification. The details for re-grouping are as follows:- Re-grouped From Re-grouped To Quarter ended Nine months ended December 31, 2022 December 31, 2022 Amount (Rs. Lakhs) Amount (Rs. Lakhs) Employee Benefits Other Comprehensive 25.47 47.42 Expense (Income)/Loss (Net of Deferred tax) 5. As a result of the sub-division of the equity shares and the re-grouping of Employee Benefits Expense, the Earnings per Share (Basic and Diluted) for the quarter ended December 31, 2022 and for the nine months ended December 31, 2022, have been re-computed and re-stated respectively, considering face value of each equity share to be Rs.2/- from Rs.9.53 to Rs.4.78 and from Rs.35.98 to Rs.18.02. 6. The Company operates in 'Styrenics and Allied Products' which in the context of Ind AS - 108 Operating Segments constitutes a single reportable business segment. 7. The above Statement of Unaudited Financial Results ( financial results ) has been prepared in accordance with the Indian Accounting Standard 34 ‘Interim Financial Reporting’ (Ind AS - 34), as prescribed under Section 133 of the Companies Act, 2013, read with the relevant rules issued thereunder. 8. The above financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on January 18, 2024. The Statutory Auditors of the Company have carried out a limited review of the above financial results for the quarter and nine months ended December 31, 2023. These financial results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, as amended. Single segment 2023-04-01 2023-12-31 Unaudited Standalone 36905015000.00 490988000.00 37396003000.00 22367851000.00 8671895000.00 436340000.00 491707000.00 55227000.00 435101000.00 2021392000.00 34479513000.00 2916490000.00 0.00 2916490000.00 758500000.00 8132000.00 766632000.00 0.00 2149858000.00 0.00 0.00 0.00 0.00 2149858000.00 -4524000.00 2145334000.00 0.00 0.00 376083000.00 2 11.43 11.43 0.00 0.00 11.43 11.43 OTHER EXPENSES 643968000.00 OTHER EXPENSES 2021392000.00 -2686000.00 -6046000.00 -593000.00 -1522000.00 0.00 0.00